Actively Recruiting
Interstitial Lung Disease Research Unit Biobank
Led by University of Kansas Medical Center · Updated on 2025-09-22
1000
Participants Needed
1
Research Sites
551 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
CONDITIONS
Official Title
Interstitial Lung Disease Research Unit Biobank
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be a patient at the University of Kansas Health System or agree to participate in a study approved by the KUMC Human Research Protection Program
- Be followed for autoimmune disease, interstitial lung disease, or other rare lung diseases at the University of Kansas Health System
- Be 18 years of age or older
- Have signed an approved consent form for this study (living patients only)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Actively Recruiting
Research Team
K
Kimberly Donnelly, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here